Nutraceutical Excipients Market Research Report – Forecast to 2027

Nutraceutical Excipients Market Information: Function (Binders, Disintegrants, Sweetener, Coating Agent), Form (Dry, Liquid), Application (Probiotics & Prebiotics, Proteins & Amino Acid), and Type (Artificial, Natural/Organic) – Global Forecast Till 2027

ID: MRFR/Pharma/4639-CR | June 2018 | Region: Global | 114 pages

Please note that the assessment period of report has been updated from 2015-2023 to 2020-2027. Cordially fill the sample form for updated data.

Global demand for nutraceutical excipient continues to move upward. Tailwinds are helping the nutraceutical industry to flourish expediently. In recent years, sales of nutraceutical products have increased to significant extents, partly owing to the increased healthcare spending in various parts of the world. Evolving eating habits and growing health consciousness among consumers is reflecting favorably on the global market for nutraceutical excipients. The market is expected to surpass a valuation of USD 4800 Mn by 2023-end. At the same time, the expansion of the wellness industry is opening new windows of growth for nutraceutical items. The aforementioned factors and trends are expected to govern the global nutraceutical excipient market during the forecast period.


Report Coverage


Market value, market share, player analysis, value chain analysis, Porter’s five forces model, demand & supply: gap analysis, investment opportunities analysis, pricing analysis, technological trends, country level break down for function, type, form, and application.


Report Overview


In this report, readers will come across information pertaining to the historical market trends, current market scenario, and relevant dynamics.  A thorough segmental analysis of the global nutraceutical excipients market is also available in the report. Binders, sweeteners, fillers, diluents & bulking agents, disintegrants, coating agents, colors & flavors, and lubricants are product functions based on which the market has been evaluated. Similarly, an evaluation of the market based on dry form and liquid form nutraceutical excipients is also offered in the report. The global nutraceutical excipients market has also been studied on the basis of application, which covers proteins & amino acids, vitamins & minerals, probiotics & prebiotics and omega-3 fatty acids. All the market segments are profiled under five key geographies– North America, South America, Europe, Asia Pacific (APAC) and the Middle East & Africa (MEA), with the respective country-level market sizing. This will allow report users to ascertain lucrative segments and identify untapped markets.


Players Covered


Cargill Corporation, Ingredion, Associated British Foods plc, Kerry, Roquette Freres SA, JRS PHARMA, Innophos, Inc., DowDupont, Sensient Technology Corporation, and Hilmar Ingredients.


MRFR in its report delivers a critical analysis on some of the leading companies operating in the global nutraceutical excipients market. This will allow report users to gain information on annual turnover, regional strength, SWOT,  M&A activities, new product launch and the latest R&D initiatives of market players discussed in the report.


Research Methodology


Market Research Future employ a selective combination of methods, which assist in a scientific and systematic approach to research of the given field of study. Primary methods such as interviews with decision makers of leading competitors in the market have been used along with secondary methods to provide a comprehensive view of the market scenario. Credible sources such as white papers, annual reports, and SEC filings have been referred as a part of objective secondary research methods. Top-down and bottom-up approaches have been applied to the field of study to provide accurate estimation and validation of the market. Our inquisitive and proficient analysts exhaust every line of research based on pertinent parameters to offer intelligent inputs and a dependable understanding of the market in its entirety.


Analysis Period



  • Base year- 2017

  • Forecast Period- 2018-2023

  • Market Denomination- USD Million


Intended Audience



  • Medical Devices Companies

  • Research and Development (R&D) Companies

  • Government Research Institutes

  • Academic Institutes and Universities


For the scope of the research, MRFR’s report offers a comprehensive segmental analysis of the global market for nutraceutical excipients 



  • Function

    • Fillers, Diluents & Bulking Agents

    • Binders

    • Disintegrants

    • Sweeteners

    • Coating Agents

    • Lubricants

    • Colors & Flavors



  • Form

    • Dry

    • Liquid



  • Application

    • Probiotics & Prebiotics 

    • Proteins & Amino Acids

    • Omega-3 Fatty Acids

    • Vitamins & Minerals



  • Type

    • Artificial

    • Natural/Organic




By Region



  • North America; The U.S., and Canada

  • Europe; Germany, the UK, France, Spain, Italy, and Rest of Europe

  • Asia Pacific (APAC); China, Japan, India and Rest of Asia Pacific

  • The Middle East & Africa (MEA)

  • South America



The global nutraceutical excipients market is anticipated to grow from USD 3.1 Bn in 2017 to USD 4.81 Bn by the end of 2023. The steadily growing demand for nutraceutical products is expected to play an important role in driving the nutraceutical excipients market in the forthcoming years.  Consumers are increasingly demanding nutraceutical products, which is supporting the growth of nutraceutical excipients sales. Excipients typically assist in the stabilization and protection of the final product from adverse and undesirable chemical reactions, making them an important preventive care product.


Factors driving the growth of the nutraceutical market and subsequently encouraging the proportional growth of the nutraceutical excipients market include changing lifestyles, a general increase in incidences of lifestyle diseases and a growing trend towards opting healthier options. The drastic increase in medical costs has had a significant impact on the nutraceutical market. Advancing healthcare technology, developing treatment options, patents on drugs which make them highly expensive and an overall increase on healthcare spending is also influencing the popularity of nutraceutical excipients worldwide. Meanwhile, stringent regulations with regard to responsible manufacture, approvals of certain chemicals derived from natural products and various other criteria are likely to limit excipient options and discourage smaller players. However, multifunctional excipients have been developed to add further nutritional value to nutraceutical formulations. Progress in the evolution of excipients is anticipated to motivate robust growth during the assessment period.


The global nutraceutical excipients market has been segmented based on function, form, application, type, and region. By function, the market has been segmented into fillers, diluents & bulking agents, binders, disintegrants, coating agents, lubricants, sweeteners, and colors & flavors. The fillers, diluents & bulking agents segment is projected to expand at a CAGR of 8.34% during the forecast period. The binders segment holds the second spot and is also likely to witness a strong growth over 2023. By form, the market has been segmented into liquid and dry, with the former currently accounting for nearly 55% share of the market and reaching a valuation of more than USD 1 Bn in 2017. The dry segment is anticipated to witness a CAGR of 7.34% during the review period. By application, the market has been segmented into probiotics & prebiotics, proteins & amino acids, omega-3 fatty acids, and vitamins & minerals. In 2017, the probiotics & prebiotics segment commanded 47.5% market share and is expected to expand at an above-average CAGR. However, the vitamins & minerals segment is set to grow at the highest CAGR of 7.92% over the course of the assessment period. By type, the market has been segmented into artificial and natural/organic. The artificial segment will continue to outperform the natural/organic segment in 2018 and beyond. However, the increased level of awareness among consumers about the benefits of natural/organic nutraceuticals products is expected to provide an impetus to the natural/organic segment.


Regional Analysis


The Americas currently lead the global nutraceutical excipients market with majority of the growth coming from developed countries in North America. Factor such as rising prevalence of chronic diseases (diabetes, respiratory infections, and cancer), increased healthcare cost, growing awareness regarding health and changing lifestyle are creating favorable conditions for the market in the region.  A strong presence of leading market players in the region has placed Europe in second place in terms of market share. Moreover, the region has a growth pattern similar to that of the Americas and is witnessing tremendous healthcare cost burdens, thus motivating growth for nutraceutical as preventative care.


The market in Asia-Pacific is growing at a rapid pace. The region comprise several developed and fast-developing countries - Japan, China, India, Australia and South Korea to name a few. During the assessment period, APAC’s market is anticipated to expand at the fastest CAGR due to the presence of a vast consumer population, steadily growing incidences of chronic diseases, increasing awareness regarding health and a growing demand for safe, innovative health products.


Competitive Dashboard


Prominent players operating in the market include Cargill Corporation, Ingredion, Associated British Foods plc., and Kerry. Cargill possessed the largest market share with 29.7% in 2017. The popular brand has a wide geographical presence across 70 countries. The key strategies that drive competition and subsequently growth is the procurement of FDA approval for unique formulations and advancements in excipients.

1 Report Prologue

2 Introduction

2.1 Definition 15

2.2 Scope of the Study 15

2.3 Research Objective 15

2.4 Assumptions & Limitations 15

2.4.1 Assumptions 15

2.4.2 Limitations 15

2.4.3 Market Structure 15

3 Research Methodology

3.1 Primary Research Methodology 17

3.2 Secondary Research Methodology 19

3.3 Market Size Estimation 20

3.4 Forecast Model 20

4 Market Dynamics

4.1 Drivers 22

4.1.1 Increasing demand for nutraceutical products 22

4.1.2 Increasing medical cost 22

4.1.3 Drivers Impact Analysis 23

4.2 Restraints 23

4.2.1 Stringent regulations for nutraceutical adversely affects the market 23

4.2.2 Restraints Impact Analysis 23

4.3 Opportunity 24

4.3.1 Multifunctional excipients 24

5 Market Factor Analysis

5.1 Value Chain Analysis 26

5.2 Raw Material & Processing 26

5.3 Separation 26

5.4 Extraction 26

5.5 Concentration 27

5.6 Packaging 27

5.7 Transportation 27

5.8 Distribution Marketing & Sales 27

5.9 Post Sales Services 27

5.10 Supply Chain Analysis 28

5.11 Porter’s Five Forces Analysis 29

5.11.1 Bargaining Power of Suppliers 29

5.11.2 Bargaining Power of Buyers 30

5.11.3 Threat of New Entrants 30

5.11.4 Threat of Substitutes 30

5.11.5 Intensity of Rivalry 30

6 Global Nutraceutical Excipients Market, By Function

6.1 Fillers, Diluents & Bulking Agents 33

6.2 Binders 33

6.3 Disintegrants 33

6.4 Sweeteners 34

6.5 Coating Agents 34

6.6 Lubricants 34

6.7 Colors & Flavors 35

7 Global Nutraceutical Excipients Market, By Form

7.1 Dry 37

7.2 Liquid 38

8 Global Nutraceutical Excipients Market, By Application

8.1 Probiotics & Prebiotics 40

8.2 Proteins & Amino Acids 41

8.3 Omega-3 Fatty Acids 41

8.4 Vitamins & Minerals 41

9 Global Nutraceutical Excipients Market, By Type

9.1 Artificial 43

9.2 Natural/Organic 44

10 Global Nutraceutical Excipients Market, By Region

10.1 Americas 47

10.1.1 North America 49

10.1.1.1 U.S. 51

10.1.1.2 Canada 52

10.1.2 South America 54


10.2 Asia Pacific 56

10.2.1 Japan 58

10.2.2 China 59

10.2.3 India 61

10.2.4 Australia 62

10.2.5 Republic of Korea 64

10.2.6 Rest of Asia Pacific 65

10.3 Europe 67

10.3.1 Western Europe 69

10.3.1.1 Germany 71

10.3.1.2 France 73

10.3.1.3 U.K. 74

10.3.1.4 Italy 75

10.3.1.5 Spain 77

10.3.1.6 Rest of Western Europe 78

10.3.2 Eastern Europe 80

10.4 Middle East & Africa 82

10.4.1 Middle East 84

10.4.2 Africa 85

11 Competitive Landscape

11.1 Introduction 88

12 Company Profiles

12.1 Roquette Freres SA 90

12.1.1 Company Overview 90

12.1.2 Financial Overview 90

12.1.3 Products Offering 90

12.1.4 Key Developments 90

12.1.5 SWOT Analysis 91

12.1.6 Key Strategy 91

12.2 Associated British Foods Inc. 92

12.2.1 Company Overview 92

12.2.2 Financial Overview 92

12.2.3 Products Offering 93

12.2.4 Key Developments 93

12.2.5 SWOT Analysis 93

12.2.6 Key Strategy 93

12.3 Ingredion Incorporated 94

12.3.1 Company Overview 94

12.3.2 Financial Overview 94

12.3.3 Products Offering 95

12.3.4 Key Developments 95

12.3.5 SWOT Analysis 95

12.3.6 Key Strategy 95

12.4 JRS PHARMA 96

12.4.1 Company Overview 96

12.4.2 Financial Overview 96

12.4.3 Products Offering 96

12.4.4 Key Developments 96

12.4.5 SWOT Analysis 96

12.4.6 Key Strategy 96

12.5 Cargill, Incorporated 97

12.5.1 Company Overview 97

12.5.2 Financial Overview 97

12.5.3 Products Offering 98

12.5.4 Key Developments 98

12.5.5 SWOT Analysis 98

12.5.6 Key Strategy 98

12.6 Innophos, Inc. 99

12.6.1 Company Overview 99

12.6.2 Financial Overview 99

12.6.3 Products Offering 100

12.6.4 Key Developments 100

12.6.5 SWOT Analysis 100

12.6.6 Key Strategy 100

12.7 DowDupont 101

12.7.1 Company Overview 101

12.7.2 Financial Overview 101

12.7.3 Products Offering 102

12.7.4 Key Developments 102

12.7.5 SWOT Analysis 102

12.7.6 Key Strategy 102

12.8 Kerry Group 103

12.8.1 Company Overview 103

12.8.2 Financial Overview 103

12.8.3 Products Offering 104

12.8.4 Key Developments 104

12.8.5 SWOT Analysis 104

12.8.6 Key Strategy 104

12.9 Sensient Technology Corporation 105

12.9.1 Company Overview 105

12.9.2 Financial Overview 105

12.9.3 Products Offering 106

12.9.4 Key Developments 106

12.9.5 SWOT Analysis 106

12.9.6 Key Strategy 106

12.10 Hilmar Ingredients 107

12.10.1 Company Overview 107

12.10.2 Financial Overview 107

12.10.3 Products Offering 107

12.10.4 Key Developments 107

12.10.5 SWOT Analysis 107

12.10.6 Key Strategy 108

13 Conclusion

13.1 Key Findings 110

13.1.1 CEO’s Viewpoint 110

13.1.2 Unmet Needs 110

13.1.3 Key Companies to Watch 110

13.1.4 Prediction of the Nutraceutical Excipient Industry 110

14 Appendix

14.1 Discussion Blue Print 112

14.2 Recent key developments 114

14.3 References 114

15 List of Tables

TABLE 1 PRIMARY INTERVIEWS 18

TABLE 2 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 32

TABLE 3 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR FILLERS, DILUENTS & BULKING AGENTS, BY REGION

2020-2027 (USD MILLION) 33

TABLE 4 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY REGION 2020-2027 (USD MILLION) 33

TABLE 5 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY REGION 2020-2027 (USD MILLION) 33

TABLE 6 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR SWEETENERS, BY REGION 2020-2027 (USD MILLION) 34

TABLE 7 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY REGION 2020-2027 (USD MILLION) 34

TABLE 8 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS, BY REGION 2020-2027 (USD MILLION) 34

TABLE 9 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR COLORS & FLAVORS, BY REGION 2020-2027 (USD MILLION) 35

TABLE 10 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 37

TABLE 11 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR DRY, BY REGION 2020-2027 (USD MILLION) 37

TABLE 12 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR LIQUID, BY REGION 2020-2027 (USD MILLION) 38

TABLE 13 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 40

TABLE 14 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR PROBIOTICS & PREBIOTICS, BY REGION 2020-2027 (USD MILLION) 40

TABLE 15 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR PROTEINS & AMINO ACIDS, BY REGION 2020-2027 (USD MILLION) 41

TABLE 16 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR OMEGA-3 FATTY ACIDS, BY REGION 2020-2027 (USD MILLION) 41

TABLE 17 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR VITAMINS & MINERALS, BY REGION 2020-2027 (USD MILLION) 41

TABLE 18 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 43

TABLE 19 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL, BY REGION 2020-2027 (USD MILLION) 43

TABLE 20 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET FOR NATURAL/ORGANIC, BY REGION 2020-2027 (USD MILLION) 44

TABLE 21 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION 2020-2027 (USD MILLION) 46

TABLE 22 AMERICAS NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION 2020-2027 (USD MILLION) 47

TABLE 23 AMERICAS NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 48

TABLE 24 AMERICAS NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 48

TABLE 25 AMERICAS NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 48

TABLE 26 AMERICAS NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 49

TABLE 27 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY 2020-2027 (USD MILLION) 49

TABLE 28 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 50

TABLE 29 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 50

TABLE 30 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 50

TABLE 31 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 51

TABLE 32 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 51

TABLE 33 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 51

TABLE 34 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 52

TABLE 35 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 52

TABLE 36 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 52

TABLE 37 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 53

TABLE 38 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 53

TABLE 39 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 53

TABLE 40 SOUTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 54

TABLE 41 SOUTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 54

TABLE 42 SOUTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 54

TABLE 43 SOUTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 55

TABLE 44 ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY/REGION 2020-2027 (USD MILLION) 56

TABLE 45 ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 57

TABLE 46 ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 57

TABLE 47 ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 57

TABLE 48 ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 58

TABLE 49 JAPAN NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 58

TABLE 50 JAPAN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 58

TABLE 51 JAPAN NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 59

TABLE 52 JAPAN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 59

TABLE 53 CHINA NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 59

TABLE 54 CHINA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 60

TABLE 55 CHINA NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 60

TABLE 56 CHINA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 60

TABLE 57 INDIA NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 61

TABLE 58 INDIA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 61

TABLE 59 INDIA NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 61

TABLE 60 INDIA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 62

TABLE 61 AUSTRALIA NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 62

TABLE 62 AUSTRALIA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 62

TABLE 63 AUSTRALIA NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 63

TABLE 64 AUSTRALIA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 63

TABLE 65 REPUBLIC OF KOREA NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 64

TABLE 66 REPUBLIC OF KOREA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 64

TABLE 67 REPUBLIC OF KOREA NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 64

TABLE 68 REPUBLIC OF KOREA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 65

TABLE 69 REST OF ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 65

TABLE 70 REST OF ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 65

TABLE 71 REST OF ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 66

TABLE 72 REST OF ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 66

TABLE 73 EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION 2020-2027 (USD MILLION) 67

TABLE 74 EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 67

TABLE 75 EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 68

TABLE 76 EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 68

TABLE 77 EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 68

TABLE 78 WESTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY/REGION 2020-2027 (USD MILLION) 69

TABLE 79 WESTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 70

TABLE 80 WESTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 70

TABLE 81 WESTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 70

TABLE 82 WESTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 71

TABLE 83 GERMANY NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 71

TABLE 84 GERMANY NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 71

TABLE 85 GERMANY NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 72

TABLE 86 GERMANY NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 72

TABLE 87 FRANCE NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 73

TABLE 88 FRANCE NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 73

TABLE 89 FRANCE NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 73

TABLE 90 FRANCE NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 74

TABLE 91 U.K. NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 74

TABLE 92 U.K. NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 74

TABLE 93 U.K. NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 75

TABLE 94 U.K. NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 75

TABLE 95 ITALY NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 75

TABLE 96 ITALY NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 76

TABLE 97 ITALY NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 76

TABLE 98 ITALY NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 76

TABLE 99 SPAIN NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 77

TABLE 100 SPAIN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 77

TABLE 101 SPAIN NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 77

TABLE 102 SPAIN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 78

TABLE 103 REST OF WESTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 78

TABLE 104 REST OF WESTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 78

TABLE 105 REST OF WESTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 79

TABLE 106 REST OF WESTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 79

TABLE 107 EASTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 80

TABLE 108 EASTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 80

TABLE 109 EASTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 80

TABLE 110 EASTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 81

TABLE 111 MIDDLE EAST & AFRICA NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION 2020-2027 (USD MILLION) 82

TABLE 112 MIDDLE EAST & AFRICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 82

TABLE 113 MIDDLE EAST & AFRICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 83

TABLE 114 MIDDLE EAST & AFRICA NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 83

TABLE 115 MIDDLE EAST & AFRICA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 83

TABLE 116 MIDDLE EAST NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 84

TABLE 117 MIDDLE EAST NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 84

TABLE 118 MIDDLE EAST NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 84

TABLE 119 MIDDLE EAST NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 85

TABLE 120 AFRICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020-2027 (USD MILLION) 85

TABLE 121 AFRICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020-2027 (USD MILLION) 85

TABLE 122 AFRICA NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 86

TABLE 123 AFRICA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020-2027 (USD MILLION) 86

16 List of Figures

FIGURE 1 TOP-DOWN & BOTTOM-UP APPROACHES 20

FIGURE 2 DROC ANALYSIS OF GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET 22

FIGURE 3 DRIVERS IMPACT ANALYSIS: GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET 23

FIGURE 4 RESTRAINTS IMPACT ANALYSIS: GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET 23

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET 26

FIGURE 6 SUPPLY CHAIN ANALYSIS OF THE GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET 28

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET 29

FIGURE 8 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTION 2020 & 2027 (USD MILLION) 32

FIGURE 9 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM 2020 & 2027 (USD MILLION) 37

FIGURE 10 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION 2020 & 2027 (USD MILLION) 40

FIGURE 11 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE 2020 & 2027 (USD MILLION) 43

FIGURE 12 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION 2020 & 2027 (USD MILLION) 46

FIGURE 13 AMERICAS NUTRACEUTICAL EXCIPIENTS MARKET SHARE, BY REGION 2020 (%) 47

FIGURE 14 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET SHARE, BY COUNTRY 2020 (%) 49

FIGURE 15 ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET SHARE, BY COUNTRY/REGION 2020 (%) 56

FIGURE 16 EUROPE NUTRACEUTICAL EXCIPIENTS MARKET SHARE, BY REGION 2020 (%) 67

FIGURE 17 WESTERN EUROPE NUTRACEUTICAL EXCIPIENTS MARKET SHARE, BY COUNTRY/REGION 2020 (%) 69

FIGURE 18 MIDDLE EAST & AFRICA NUTRACEUTICAL EXCIPIENTS MARKET SHARE, BY REGION 2020 (%) 82

FIGURE 19 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET COMPANY SHARE ANALYSIS, 2020 (%) 88

Global Nutraceutical Excipients Market: Competitive Landscape


Top four companies including Cargill, Ingredion, Associated British Foods plc, and Kerry collectively accounted for about 68% of the global nutraceutical excipients market in 2017. These companies are likely to maintain their strong market position through collaborations, mergers & acquisitions, and product launches.


In 2017, Cargill accounted for the largest market share of 29.7% of the global nutraceutical excipients market. Cargill is a leading manufacturer of nutraceutical excipients, serves various food manufacturers, food service companies, and retailers with its excipients. The company with its brand popularity and wide geographical presence (70 countries) in various regions has been able to achieve a steadfast growth.


Ingredion held the second position in terms of market share, in 2017. The company with its organic growth in more than 40 countries, is servicing more than 120 customers and generating revenue from all around the globe. The company with its strong presence in the North American region commands maximum share of the region’s market.


Associated British Foods plc (ABF) holds the third position with a global market share of 9.5%. ABF’s growth primarily comes from the higher proportion of revenues from the premium markets.


In 2017, Kerry accounted for about 8.8% of the total nutraceutical excipients market. The company enjoys its maximum market share in the North America. The company with its taste and nutrition business segments enhances its revenue in global nutraceutical excipients.


There are several other big-sized players currently operating in the market including Roquette Freres SA, JRS PHARMA, Innophos, Inc., DowDupont, Sensient Technology Corporation, and Hilmar Ingredients. These companies are actively focusing on growth strategies such as acquisitions, new product development and expansion in untapped markets.